ciprofloxacin

Generic: ciprofolxacin

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ciprofloxacin
Generic Name ciprofolxacin
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ciprofloxacin hydrochloride 250 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7297
Product ID 50090-7297_fa78032d-254d-4305-afe9-f672e95aea29
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208921
Listing Expiration 2026-12-31
Marketing Start 2023-10-01

Pharmacologic Class

Classes
cytochrome p450 1a2 inhibitors [moa] fluoroquinolone antibacterial [epc] fluoroquinolones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907297
Hyphenated Format 50090-7297

Supplemental Identifiers

RxCUI
197511
UNII
4BA73M5E37

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ciprofloxacin (source: ndc)
Generic Name ciprofolxacin (source: ndc)
Application Number ANDA208921 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 6 TABLET in 1 BOTTLE (50090-7297-0)
  • 14 TABLET in 1 BOTTLE (50090-7297-1)
  • 10 TABLET in 1 BOTTLE (50090-7297-2)
  • 3 TABLET in 1 BOTTLE (50090-7297-3)
source: ndc

Packages (4)

Ingredients (1)

ciprofloxacin hydrochloride (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fa78032d-254d-4305-afe9-f672e95aea29", "openfda": {"unii": ["4BA73M5E37"], "rxcui": ["197511"], "spl_set_id": ["cfe9e173-1d3a-4455-a9d3-fb953bebbe37"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET in 1 BOTTLE (50090-7297-0)", "package_ndc": "50090-7297-0", "marketing_start_date": "20241010"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (50090-7297-1)", "package_ndc": "50090-7297-1", "marketing_start_date": "20241010"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (50090-7297-2)", "package_ndc": "50090-7297-2", "marketing_start_date": "20241010"}, {"sample": false, "description": "3 TABLET in 1 BOTTLE (50090-7297-3)", "package_ndc": "50090-7297-3", "marketing_start_date": "20241010"}], "brand_name": "Ciprofloxacin", "product_id": "50090-7297_fa78032d-254d-4305-afe9-f672e95aea29", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Fluoroquinolone Antibacterial [EPC]", "Fluoroquinolones [CS]"], "product_ndc": "50090-7297", "generic_name": "Ciprofolxacin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ciprofloxacin", "active_ingredients": [{"name": "CIPROFLOXACIN HYDROCHLORIDE", "strength": "250 mg/1"}], "application_number": "ANDA208921", "marketing_category": "ANDA", "marketing_start_date": "20231001", "listing_expiration_date": "20261231"}